Veeva And Zifo Partner To Streamline Biopharma Quality Control
Partnership streamlines QC processes with integrated digital solutions.

.webp&w=1920&q=75&dpl=dpl_DeN36yrCPuhMyPQWp9gtZrBJx2ZM)
Veeva Systems and Zifo landed into a collaboration to make quality control processes in the biopharma industry smoother and more efficient. By combining Veeva’s cloud-based Laboratory Information Management System (LIMS) with Zifo’s qcKen platform, companies can quickly transfer data from various sources into Veeva LIMS. This integration simplifies setup and deployment, helping businesses avoid outdated QC systems.
Kannan Jagamoorthy, general manager and head of Zifo North America, said in a statement, “We are excited to partner with Veeva to offer powerful solutions to the life sciences industry. Our collaboration will help customers expedite their adoption of Veeva LIMS to streamline operations.”
With Veeva, businesses can manage quality assurance and quality control more closely, ensuring Good Manufacturing Practices (GMP) with better accuracy. Zifo’s qcKen will speed up the creation of test and specification data, simplify implementation, and help companies see quicker returns on their investment in Veeva LIMS. Zifo, now an official Veeva Product Partner, strengthens its collaboration with Veeva, building on its existing service provider partnership.
“Veeva LIMS is designed specifically for life sciences organisations looking to advance their QC operations, increase scale, and speed batch release cycles. Partnering with Zifo allows customers to implement Veeva LIMS and realise value much quicker, accelerating QC modernisation initiatives,” said Ashley McMillan, senior director Of Veeva LIMS strategy.

Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.
More from Pharma News
All stories →
Tonix Plans Adaptive Phase 2 Trial for Seasonal Lyme Disease Prevention Therapy, Advances Program Following FDA Type C Meeting

Medicus Pharma Appoints Dr. Faisal Mehmud as CEO of UK Subsidiary Antev, Strengthens Leadership to Advance Global Development of Teverelix®

Discussion